99¦~04¤ë¸¹ ¹D ªk ªk °T (216)

DEEP & FAR

 

 

«IÅv®×¯A¤Î¤ºÁô¹w´Á°ÝÃD

 

³¯ºaºÖ ±M§Q¥N²z¤H

¡E¤¤°êÂåÃľǰ|ÃľǨt¾Ç¤h

¡E¤é¥»ºÖ©£¤j¾Ç¥ÍÃľǩҺӤh

¡E¶§©ú¤j¾ÇÂå¾ÇÃIJz©Ò³Õ¤h

 

 

¤G¡BAstra Aktiebolag v. Andrx Pharm., Inc.(14)

Andrx ¤§"¤£²M¥Õ" ¡B¶B´Û¥H¤Î¤£¤½¥­¦æ¬°¤§ª§ÅG¡A¨ü­­©óÁp¨¹¦a¤èªk°|¤§­­¨î¤ñ¦b¥»°|§ó¦h¡C¦bÁp¨¹¦a¤èªk°|¡AAndrx ´£¥X"µo©úªÌ¤§«Å»}"¦ÓÁnºÙ¡u281 µo©úªÌ¡A¨Ã«D¯u¹ê'281 ±M§Q©Ò½Ð¨D»sµ{¤§µo©ú¤H¡v¡C¸Ó¤£¤½¥­¦æ¬°²[»\¦b'505 ©M'230 ±M§Q¤§¥Ó½Ð´Á¶¡¡AÁp¨¹¦a¤èªk°|«ü¥X:

ªk°|¦b¦^ÅU¼Æ¦Ê­¶Andrx©Ò»¼¥æ¡A¦³Ãö©Òµo²{¤§¨Æ¹ê»Pªk«ßµ²½×¡A¥H¤ä«ù¨ä¤£²M¥Õ²z½×¡Aªk°|§¹¥þ¥¼³Q»¡ªA[1]¡C

§@¬°¤£²M¥Õ¤§ÃÒ¾Ú¡AAndrx ÁnºÙ¡u (1) ¼f§P©µ¿ð; (2)ªÖ©w¹B¥Î¦Ã¬V¤§ÃÒ¾Ú; ¨Ã¥B(3) ª½¨ì¶¥¬qI ©MII ¼f§P§¹¦¨«á¡A¤´¦©À£µÛ­«­n¤å¥ó¡C[2]¡v

Áp¨¹¦a¤èªk°|»{¬°Andrx ©MAstra¦P¼Ë¦a¯A¤Î©µ¿ð¡C¦Ó¼f§Pªk®x¥ç¯d·N¨ìAndrx¡A¦Ó«DAstras´¿¸g½Ð¨D'281 ±M§QÀH¦P'505 ©M'230 ±M§Q¼f§P[3]¡C¦Ó¦b¥»°|¤§«e¡AAndrx ¥ø¹Ïª§ÅGAstra ¤§µo©úªÌ¹ïPTO»~³¯¨Æ¹ê¡A¥B¬G·N¦a¥¼¹ïPTO³zÅSÁú°ê¶D³^©MKIPO µ{§Ç¡CAndrx ¥¼¾A·í¦a¦bÁp¨¹¦a¤èªk°|´£¥X¤§¼f§P«á¨Æ¹êµo²{¤§°ÝÃD¡A¥»°|¤£»Ý­n¦^À³¡C[4]

Áp¨¹¦a¤èªk°|ªí¥Ü¡A"Ãö©óAndrx¹ï'281 ±M§Q¤§ÃB¥~¨¾¿m¡A¦]¨äŲ©ó¥»°|»{©w'281 ±M§Q¦U½Ð¨D¶µµL®Ä¤§§P¨MµL·N¸q"¡A¬G¤£·|¶i¦æ¸Ô²Ó¤§¬ã¨s[5]¡C¤£¤½¥­¦æ¬°¤§½Ð¨DµL¶·±q§Þ³N¤W°Q½×¡A¦]¬°±N¨Ï¾ã­Ó'281 ±M§QµLªk¹ê¬I¡A¦Ó«D¶È«Y³Q»{©wµL®Ä¤§½Ð¨D¶µ¡CµM¦Óªk®x´N¤ð»Ý°Q½×¤§µô©w¡A¹ï©óAndrx¨ÃµL°¾¨£¡A¦]¬°¬ö¿ý¥¼¦³¤ä«ùAndrx¹ï©ó'281 ±M§Qµo©úªÌ¦bPTO¤§¦æ¬°«Yºc¦¨¤£¤½¥­¦æ¬°¤§ª§ÅG¡C

  



[1] Omeprazole III, slip op. at 37-38.

[2] Id., slip op. at 37

[3] Id., slip op. at 38.

[4] Viskase Corp. v. Am. Nat¡¦l Can Co., 261 F.3d 1316, 1326 (Fed. Cir. 2001).

[5] Omeprazole III, slip op. at 37.